ColoPrint® Development and Validation


ColoPrint is currently in the validation stage and scheduled to be launched in 2010.  Agendia is actively engaging academic centers and medical institutions throughout the USA and internationally to participate in the PARSC clinical trial.

For more information about participation in the PARSC trial, please visit the PARSC Clinical Trial for Colon Cancer page.